Showing 631-640 of 791 results for "".
Cannabinoid Photo-Rejuvenation: A Clinico-Pathologic Study
https://practicaldermatology.com/topics/feature/cannabinoid-photo-rejuvenation-a-clinico-pathologic-study/29188/In this study, we sought to assess the effectiveness of a novel topical formulation containing CBD isolate, resveratrol, thyme extract, caffeine, and lecithin in reversing photodamage over a 90-day treatment period.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-4/23071/Empathy and Transactional Medicine: Improving Patient and Physician Outcomes
https://practicaldermatology.com/topics/skin-cancer-photoprotection/transactional-medicine-improving-patient-and-physician-outcomes/20316/For each individual patient, the patient-physician interaction is unique and requires vulnerability, exposure, and discomfort.Tinea Incognito, the Great Imitator: Case Reports
https://practicaldermatology.com/youngmd-connect/resident-resource-center/tinea-incognito-the-great-imitator-case-reports/23925/Topical Treatment Options for Hyperhidrosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/topical-treatment-options-for-hyperhidrosis/23340/A review of topical therapies for primary focal hyperhidrosisDigital Innovation to the Rescue: The Future of Electronic Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/digital-innovation-to-the-rescue-the-future-of-electronic-prior-authorization-in-dermatology/20467/Adopting new technology to reduce paperwork, costs, and burnout as well as improve patient care.Updating Approaches to Psoriasis
https://practicaldermatology.com/topics/psoriasis/evaluating-the-state-of-psoriasis-care/21660/Recent guidelines from the National Psoriasis Foundation point to new directions in research and therapy that will continue to shape psoriasis therapy.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.New Directions in Acne Care
https://practicaldermatology.com/topics/acne-rosacea/new-directions-in-acne-care/23515/Recent developments and therapeutic advancements continue to improve outcomes in the management of this common, inflammatory disease.